Alida Biosciences is a provider of technology for RNA analysis to improve human health. The company offers new technologies in RNA biology to develop medical treatments and diagnostic assays, operating in the genomics space. The companys platform focuses on epitranscriptomic analysis, enabling researchers to understand RNA modifications and their role in disease mechanisms, which can lead to new therapeutic targets and diagnostic tools. Founded in 2020 and headquartered in San Diego, United States, Alida Biosciences has raised approximately 11.5 million at the Series A stage with 18 employees and investors including Genoa Ventures, FusionX Ventures, Vertical Venture Partners, and HHS.
← All startups
Alida Biosciences
Series AAlida Biosciences is a provider of technology for RNA analysis to improve human health. The company offers new technologies in RNA biology to develop medical treatments and diagnostic assays, operating in the genomics space. The companys platform focuses on epitranscriptomic analysis, enabling researchers to understand RNA modifications and their role in disease mechanisms, which can lead to new therapeutic targets…
About
Business model
Genomics > Applied Genomics > Clinical Genomics > Diagnostics > Sequencing-based > Genetic Diagnosis > Transcriptomics > Coding RNA
Institutional investors
Genoa VenturesFusionX VenturesVertical Venture PartnersHHS
Latest coverage
📰 See all funding news — keep up with the raises that set comps.
Investor directory
🗂️ Explore Life Sciences investors — funds that write checks in this sector.